Freyr supports pharmaceutical companies in Japan with full-end-to-end eCTD v4.0 services for PMDA submissions. From dossier preparation, XML publishing, validation, and submission to post-submission support, training, and readiness gap-analysis — all aligned with Japan-specific requirements. Get compliant by 2026 https://japan.freyrsolutions.com/freyr-japan-pmda-ectd-v4-0-submissions-services-and-solutions